The HemOnc Pulse

Evolving Approaches in the Management of MDS


Listen Later

Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew Brunner, MD.

...more
View all episodesView all episodes
Download on the App Store

The HemOnc PulseBy Rahul Banerjee, MD

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

27 ratings